Staphylococcus aureus bacteremia and cardiac implantable electronic devices in a county hospital setting: a population-based retrospective cohort study

• Published in: Upsala journal of medical sciences Vol. 126; no. 1; pp. e5653 - 8
• Main Authors: Pichtchoulin, Sara, Selmeryd, Ingrid, Freyhult, Elisabeth, Hedberg, Pär, Selmeryd, Jonas
• Format: Journal Article
• Language: English
• Published: Sweden Open Academia 2021; Upsala Medical Society
• Subjects: Age; Aged; Bacteremia - etiology; Bacteremia - therapy; cardiac implantable electronic device; Cohort analysis; Comorbidity; Defibrillators, Implantable - adverse effects; Electronics; Endocarditis; Generalized linear models; Hospital Mortality; Hospitals, County; Humans; Neoplasm Recurrence, Local; Nursing homes; Original; pacemaker; Pacemakers; Population-based studies; Prosthesis-Related Infections - therapy; Retrospective Studies; Staphylococcus aureus; Staphylococcus infections; Variables; Sweden; endocarditis; pacemaker; Staphylococcus aureus; cardiac implantable electronic device
• ISSN: 0300-9734; 2000-1967; 2000-1967
• DOI: 10.48101/ujms.v126.5653

Background: Due to a high incidence of cardiac implantable electronic device-associated infective endocarditis (CIED-IE) in cases of Staphylococcus aureus bacteremia (SAB) and high mortality with conservative management, guidelines advocate device removal in all subjects with SAB. We aimed to investigate the clinical course of SAB in patients with a CIED (SAB+CIED) in a Swedish county hospital setting and relate it to guideline recommendations. Methods: All CIED carriers with SAB, excluding clinical pocket infections, in the County of Västmanland during 2010–2017 were reviewed retrospectively. Results: There were 61 cases of SAB+CIED during the study period, and CIED-IE was diagnosed in 13/61 (21%) cases. In-hospital death occurred in 19/61 (31%) cases, 34/61 (56%) cases were discharged with CIED device retained, and 8/61 (13%) cases were discharged after device removal. Subjects dying during hospitalization were elderly and diseased. No events was seen if the CIED was removed. Among four discharged cases with conservatively managed CIED-IE one relapse occured. Among 30 cases discharged with retained CIED and no evidence of IE, 22/30 (73%) cases had an uneventful follow-up, whereas adverse events secondary to overlooked CIED-IE were likely in 1/30 (3%) cases and could not be definitely excluded in additionally 4/30 (13%) cases. Conclusions: During the study period, management became more active and prognosis improved. The heterogeneity within the population of SAB+CIED suggests that a management strategy based on an individual risk/benefit analysis could be an alternative to mandatory device removal.